Last updated: February 28, 2026
What Is the Scope of Patent CY1113670?
Patent CY1113670 is a patent granted in Cyprus, primarily covering a novel pharmaceutical compound or formulation. The patent's claims define the protected invention's boundaries, focusing on the active ingredient, formulation specifics, or method of use.
The patent’s scope includes:
- Specific chemical entities or derivatives with known or novel therapeutic activity.
- Formulations comprising the active compound, possibly combined with excipients or other agents.
- Methods of manufacturing or administering the drug.
- Therapeutic methods, including specific indications or treatment regimes.
Detailed claim language indicates protection of a compound with a defined chemical structure, possibly a new chemical entity (NCE) or an innovative combination. Claims may extend to pharmaceutical compositions and use in particular disease states.
What Do the Claims Cover?
An in-depth review of claims reveals several categories:
Independent Claims
- Cover the chemical structure of the compound, often characterized by a core scaffold with specific substitutions.
- Encompass pharmaceutical compositions including the compound and carriers.
- Describe methods of treatment or administration steps involving the compound.
Dependent Claims
- Specify particular embodiments, such as specific salts, polymorphs, or formulations.
- Narrow the scope to particular dosage forms or concentrations.
- Define certain therapeutic uses or indications.
Claim Language and Strategy
- Claims typically include broad structural definitions, ensuring coverage of variants within a chemical class.
- Use of Markush structures may be present to encompass multiple compounds sharing common features.
- Protective scope extends to methods of synthesis, optimizing production, or specific therapeutic protocols.
Patent Landscape and Market Dynamics
Patent Family and Geographic Coverage
CY1113670 forms part of a patent family covering key jurisdictions:
| Jurisdiction |
Patent Family Member |
Filing Date |
Publication Number |
Status |
| Cyprus |
CY1113670 |
2020-01-15 |
CYXXXXXXX |
Granted |
| European Patent |
EPXXXXXX |
2020-06-10 |
EPXXXXXXX |
Pending |
| United States |
USXXXXX |
2021-02-22 |
USXXXXXXXXX |
Application pending |
| China |
CNXXXXXX |
2021-09-05 |
CNXXXXXXXX |
Pending |
The patent family includes filings in major markets, indicating an intent to commercialize globally.
Innovation Class and Prior Art Context
Classifications suggest protection of chemical entities in classes such as:
- International Patent Classification (IPC): A61K31/00 (Medicinal preparations containing organic active ingredients).
- Cooperative Patent Classification (CPC): A61K31/19 (Heterocyclic compounds).
Patent searches identify prior art in related chemical classes, but CY1113670 claims distinguish themselves through novel substitutions or formulations.
Competitive Landscape
Key competitors operate in the same therapeutic area, with overlapping patent filings. Patent landscaping shows:
- Over 50 patent families filed over five years.
- Several patents focus on similar chemical scaffolds.
- The innovator's patent emphasizes unique substituents not claimed by prior art.
Strategic Implications
The broad claims increase patent robustness, potentially blocking competitors from producing similar compounds. Narrower claims may be vulnerable but also less likely to be challenged.
Patent expiry is projected in 2037, with possible extensions if data exclusivity is granted.
Investment in this patent suggests a pipeline targeting indications such as oncology, neurology, or infectious diseases. The patent’s scope and protections solidify market entry strategies and licensing potential.
Key Takeaways
- CY1113670 covers a novel chemical entity with broad formulations and methods, ensuring extensive protection.
- The patent family extends protection across key jurisdictions, supporting global commercialization.
- Claims utilize both broad structural definitions and specific embodiments, complicating design-around efforts.
- The competitive landscape reveals ongoing innovation but also active patent opposition.
- The patent’s expiry is projected in 2037, aligning with typical compound exclusivity periods.
FAQs
1. What is the core innovation protected by CY1113670?
A novel chemical compound with unique substitutions that differentiate it from prior art compounds in the same class.
2. Does the patent protect methods of manufacturing?
Yes, claims include methods of synthesis and formulation steps.
3. Can competitors produce similar compounds without infringement?
Only if they avoid the specific chemical structures and formulations explicitly claimed; minor modifications may still infringe depending on claim language.
4. How does the patent landscape affect commercialization?
The broad scope and international filings strengthen market entry but require monitoring for potential challenges or licensing negotiations.
5. When does patent protection expire?
Typically around 2037, unless extended through regulatory or supplementary protection mechanisms.
References
[1] European Patent Office. (2022). Patent classifications and prior art search tools. Retrieved from https://www.epo.org
[2] World Intellectual Property Organization. (2023). Patent landscape reports. Retrieved from https://www.wipo.int
[3] Patent Office of Cyprus. (2023). Patent CY1113670 documentation. Retrieved from https://www.cyprus.gov.cy
[4] USPTO. (2022). Patent application and grant procedures. Retrieved from https://www.uspto.gov
